JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Начало・Списък с акции・Altimmune Inc

Altimmune Inc

Затворен

5.11

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.02

Максимум

5.25

Ключови измерители
By Trading Economics
Приходи	3.1M -19M
Продажби	5K
Марж на печалбата	-380,280
Служители	59
EBITDA	4.4M -18M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+199.41% upside

Дивиденти
By Dow Jones
Следващи печалби	26.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	241M 591M
Предишно отваряне	5.11
Предишно затваряне	5.11

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

5.365 / 6.0486 Подкрепа & съпротива

Altimmune Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.01.2026 г., 22:31 ч. UTC

Печалби

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29.01.2026 г., 22:05 ч. UTC

Печалби

Stryker Logs Higher 4Q Profit On Sales Gains

29.01.2026 г., 21:54 ч. UTC

Печалби

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29.01.2026 г., 21:36 ч. UTC

Печалби

Visa 1Q Sales Climb on Strong Holiday Shopping

29.01.2026 г., 23:57 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29.01.2026 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29.01.2026 г., 23:53 ч. UTC

Придобивния, сливания и поглъщания

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29.01.2026 г., 23:51 ч. UTC

Печалби

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29.01.2026 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29.01.2026 г., 23:49 ч. UTC

Пазарно говорене

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29.01.2026 г., 23:35 ч. UTC

Печалби

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29.01.2026 г., 23:32 ч. UTC

Пазарно говорене

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29.01.2026 г., 23:32 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

29.01.2026 г., 23:15 ч. UTC

Пазарно говорене

Печалби

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29.01.2026 г., 22:27 ч. UTC

Печалби

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29.01.2026 г., 22:27 ч. UTC

Печалби

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29.01.2026 г., 22:12 ч. UTC

Печалби

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29.01.2026 г., 21:55 ч. UTC

Печалби

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Financial Services Roundup: Market Talk

29.01.2026 г., 21:50 ч. UTC

Печалби

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Health Care Roundup: Market Talk

29.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

29.01.2026 г., 21:49 ч. UTC

Печалби

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29.01.2026 г., 21:46 ч. UTC

Печалби

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29.01.2026 г., 21:36 ч. UTC

Печалби

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29.01.2026 г., 21:32 ч. UTC

Печалби

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29.01.2026 г., 21:32 ч. UTC

Печалби

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29.01.2026 г., 21:30 ч. UTC

Печалби

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29.01.2026 г., 21:30 ч. UTC

Печалби

Apple 1Q Mac Rev $8.39B >AAPL

Сравнение с други в отрасъла

Ценова промяна

Altimmune Inc Прогноза

Ценова цел

By TipRanks

199.41% нагоре

12-месечна прогноза

Среден 15.33 USD 199.41%

Висок 20 USD

Нисък 12 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Altimmune Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Altimmune Inc през последните 3 месеца.

Техническа оценка

By Trading Central

5.365 / 6.0486Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bearish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.